TMCnet News
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Taro Pharmaceutical Industries Ltd. and Certain Officers and DirectorsLevi & Korsinsky, LLP announces that it has commenced an investigation of Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") (NYSE: TARO) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. On September 9, 2016, Taro disclosed it and two of its senior officers received grand jury subpoenas in connection with a federal antitrust investigation into generic drug pricing. On this news, shares of Taro Pharmaceutical fell 4% on September 12, 2016. To obtain additional information about the investigation, go to: http://zlk.9nl.com/taro-pharmaceutical-taro or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161020006371/en/ |
